During the past decade, Penn Memory Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn Memory Center" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials, followed by "Biogen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "University of Pennsylvania" with 2 trials sponsored and "Amylyx Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn Memory Center" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Penn Memory Center" are "Alzheimer's Disease" (8 trials), "Alzheimer Disease" (3 trials), "Dementia" (1 trials), "Memory Impairment" (1 trials) and "Mild Cognitive Impairment" (1 trials). Many other conditions were trialed in "Penn Memory Center" in a lesser frequency.

Most popular intervention types in "Penn Memory Center" are "Drug" (11 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo" (2 trials), "Placebo Control" (2 trials) and "bapineuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Penn Memory Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Penn Memory Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Penn Memory Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Penn Memory Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".